Matches in Nanopublications for { ?s ?p "[In hemoglobinopathies, treatment with demethylating agents leads to reactivation of fetal HbF (the gamma-globin gene locus also possibly being another target for reactivation in MDS), and thus, HbF may potentially act as surrogate marker for activity of decitabine.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 4 of
4
with 100 items per page.
- NP503052.RAgbF1IlRV8eho3_UwXYbxSJiAgYIiEqckX2I1-deET4k130_assertion description "[In hemoglobinopathies, treatment with demethylating agents leads to reactivation of fetal HbF (the gamma-globin gene locus also possibly being another target for reactivation in MDS), and thus, HbF may potentially act as surrogate marker for activity of decitabine.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP503052.RAgbF1IlRV8eho3_UwXYbxSJiAgYIiEqckX2I1-deET4k130_provenance.
- NP824583.RAt-d0dKIThFB0e_QKTGVfjXOsyINJI86l1QwDv_rUbs8130_assertion description "[In hemoglobinopathies, treatment with demethylating agents leads to reactivation of fetal HbF (the gamma-globin gene locus also possibly being another target for reactivation in MDS), and thus, HbF may potentially act as surrogate marker for activity of decitabine.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP824583.RAt-d0dKIThFB0e_QKTGVfjXOsyINJI86l1QwDv_rUbs8130_provenance.
- assertion description "[In hemoglobinopathies, treatment with demethylating agents leads to reactivation of fetal HbF (the gamma-globin gene locus also possibly being another target for reactivation in MDS), and thus, HbF may potentially act as surrogate marker for activity of decitabine.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[In hemoglobinopathies, treatment with demethylating agents leads to reactivation of fetal HbF (the gamma-globin gene locus also possibly being another target for reactivation in MDS), and thus, HbF may potentially act as surrogate marker for activity of decitabine.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.